Market Closed -
NSE India S.E.
12:43:52 15/05/2024 BST
|
5-day change
|
1st Jan Change
|
704.4
INR
|
+0.56%
|
|
+2.46%
|
-6.18%
|
Fiscal Period: March |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
121,036
|
77,513
|
84,196
|
-
|
-
|
Enterprise Value (EV)
1 |
122,118
|
74,675
|
82,183
|
82,728
|
83,324
|
P/E ratio
|
119
x
|
156
x
|
162
x
|
74
x
|
44.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.2
x
|
1.7
x
|
1.49
x
|
1.23
x
|
1.04
x
|
EV / Revenue
|
3.23
x
|
1.64
x
|
1.45
x
|
1.2
x
|
1.03
x
|
EV / EBITDA
|
44.8
x
|
28.1
x
|
23.4
x
|
17.4
x
|
13.7
x
|
EV / FCF
|
234
x
|
-95
x
|
80.2
x
|
33.5
x
|
24.9
x
|
FCF Yield
|
0.43%
|
-1.05%
|
1.25%
|
2.99%
|
4.02%
|
Price to Book
|
17.1
x
|
10.4
x
|
5.45
x
|
5.1
x
|
4.59
x
|
Nbr of stocks (in thousands)
|
119,306
|
119,306
|
119,537
|
-
|
-
|
Reference price
2 |
1,014
|
649.7
|
704.4
|
704.4
|
704.4
|
Announcement Date
|
30/05/22
|
25/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
37,793
|
45,576
|
56,682
|
68,721
|
80,610
|
EBITDA
1 |
-
|
2,724
|
2,657
|
3,512
|
4,767
|
6,071
|
EBIT
1 |
-
|
1,530
|
841.1
|
1,280
|
2,267
|
3,313
|
Operating Margin
|
-
|
4.05%
|
1.85%
|
2.26%
|
3.3%
|
4.11%
|
Earnings before Tax (EBT)
1 |
-
|
1,179
|
471.6
|
669.8
|
1,514
|
2,530
|
Net income
1 |
638.6
|
958
|
497.6
|
518.4
|
1,137
|
1,890
|
Net margin
|
-
|
2.53%
|
1.09%
|
0.91%
|
1.66%
|
2.34%
|
EPS
2 |
29.38
|
8.520
|
4.170
|
4.354
|
9.524
|
15.83
|
Free Cash Flow
1 |
-
|
521.7
|
-786
|
1,024
|
2,472
|
3,348
|
FCF margin
|
-
|
1.38%
|
-1.72%
|
1.81%
|
3.6%
|
4.15%
|
FCF Conversion (EBITDA)
|
-
|
19.15%
|
-
|
29.17%
|
51.87%
|
55.15%
|
FCF Conversion (Net income)
|
-
|
54.45%
|
-
|
197.63%
|
217.38%
|
177.14%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18/08/21
|
30/05/22
|
25/05/23
|
-
|
-
|
-
|
Fiscal Period: March |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
9,659
|
9,937
|
11,206
|
11,903
|
12,530
|
12,843
|
14,058
|
14,502
|
14,890
|
EBITDA
1 |
-
|
522.8
|
526.4
|
596.7
|
717.2
|
816.3
|
713.4
|
676.7
|
622
|
823.7
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
162.1
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
171.7
|
-
|
32
|
65.65
|
134.1
|
265.8
|
37.86
|
93.5
|
111
|
182.7
|
Net margin
|
-
|
-
|
0.32%
|
0.59%
|
1.13%
|
2.12%
|
0.29%
|
0.67%
|
0.77%
|
1.23%
|
EPS
|
1.520
|
-
|
-
|
-
|
1.120
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/02/22
|
30/05/22
|
10/08/22
|
11/11/22
|
03/02/23
|
25/05/23
|
07/08/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
1,083
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
2,838
|
2,013
|
1,468
|
872
|
Leverage (Debt/EBITDA)
|
-
|
0.3975
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
522
|
-786
|
1,025
|
2,473
|
3,348
|
ROE (net income / shareholders' equity)
|
-
|
8.92%
|
3.42%
|
3.28%
|
7.08%
|
10.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
59.40
|
62.50
|
129.0
|
138.0
|
154.0
|
Cash Flow per Share
|
-
|
-
|
7.580
|
-
|
-
|
-
|
Capex
1 |
-
|
1,142
|
1,690
|
811
|
791
|
875
|
Capex / Sales
|
-
|
3.02%
|
3.71%
|
1.43%
|
1.15%
|
1.09%
|
Announcement Date
|
18/08/21
|
30/05/22
|
25/05/23
|
-
|
-
|
-
|
Last Close Price
704.4
INR Average target price
878.4
INR Spread / Average Target +24.71% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.18% | 1B | | -31.33% | 15.83B | | -22.89% | 12.31B | | -24.53% | 6.59B | | +12.51% | 6.45B | | -12.43% | 5.94B | | -0.15% | 4.66B | | +62.00% | 4.59B | | -5.94% | 3.96B | | -8.76% | 3.55B |
Other Drug Retailers
|